Indefinite course of osimertinib dramatically improves PFS in stage 3 EGFR-mutated NSCLC

At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer

If you believe in the miraculous healing power of ivermectin, hydroxychloroquine, and the harm from vaccination for HPV and COVID-19, you’ve got a powerful friend in Sen. Ron Johnson (R-WI), chair of the Permanent Subcommittee on Investigations of the Senate Committee on Homeland Security and Governmental Affairs.

June 05, 2026

Vol.52 No.22

By Sara Willa Ernst, Claire Marie Porter and Paul Goldberg

Eric Small, ASCO’s immediate past president, speaks on the toll of toxicity—financial, emotional, physical—in cancer
“Discovery alone is not enough. It’s about what becomes of what we discover. It’s about translation.”

In a poignant keynote punctuated with anecdotes about grief, American Society of Clinical Oncology’s immediate past president Eric Small emphasized that the annual conference is not just about scientific discovery, but about a responsibility to translate discoveries into better outcomes for cancer patients globally.

June 05, 2026

Vol.52 No.22

By Claire Marie Porter

Cancer Policy

Cancer patients could be exempted from Medicaid work requirements if they prove they are “medically frail”

The Centers for Medicare & Medicaid Services has released a guidance for states on how to implement Medicaid work requirements that will go into effect nationwide on Jan. 1, 2027.

OpenEvidence integrates ASCO guidelines, figures, and flowcharts into specialty oncology model

OpenEvidence announced an integration of ASCO Guidelines, figures, and flowcharts into the OpenEvidence model.

June 05, 2026

Vol.52 No.22

Clinical Roundup

GRAIL reports full results from NHS-Galleri trial at ASCO

GRAIL Inc. presented more detailed results of the NHS-Galleri trial in an oral presentation at the 2026 American Society of Clinical Oncology annual meeting.

June 05, 2026

Vol.52 No.22

Podcast

Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes

At the American Society of Clinical Oncology annual meeting, the plenary sessions are one of the main events. A handful of clinical research studies are chosen from the thousands that are presented at the conference to represent the biggest achievements from the field in the last year.

June 03, 2026

Indefinite course of osimertinib dramatically improves PFS in stage 3 EGFR-mutated NSCLC

YOU MAY BE INTERESTED IN

At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer

Eric Small, ASCO’s immediate past president, speaks on the toll of toxicity—financial, emotional, physical—in cancer
“Discovery alone is not enough. It’s about what becomes of what we discover. It’s about translation.”

Cancer patients could be exempted from Medicaid work requirements if they prove they are “medically frail”

OpenEvidence integrates ASCO guidelines, figures, and flowcharts into specialty oncology model

GRAIL reports full results from NHS-Galleri trial at ASCO

Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes

Renew today!

Subscriber content

Never miss an issue!

Login

Indefinite course of osimertinib dramatically improves PFS in stage 3 EGFR-mutated NSCLC

YOU MAY BE INTERESTED IN

At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer

Eric Small, ASCO’s immediate past president, speaks on the toll of toxicity—financial, emotional, physical—in cancer“Discovery alone is not enough. It’s about what becomes of what we discover. It’s about translation.”

Cancer patients could be exempted from Medicaid work requirements if they prove they are “medically frail”

OpenEvidence integrates ASCO guidelines, figures, and flowcharts into specialty oncology model

GRAIL reports full results from NHS-Galleri trial at ASCO

Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes

Never miss an issue!

Login

Eric Small, ASCO’s immediate past president, speaks on the toll of toxicity—financial, emotional, physical—in cancer
“Discovery alone is not enough. It’s about what becomes of what we discover. It’s about translation.”